JPRN-UMIN000019902已完成2 期
An investigation of antitumor effectiveness using M-VAC/CaG prediction system in neoadjuvant chemotherapy for muscle invasive bladder cancer. - An investigation of antitumor effectiveness using M-VAC/CaG prediction system in neoadjuvant chemotherapy for muscle invasive bladder cancer.
Department of Urology, Iwate Medical University0 个研究点目标入组 35 人开始时间: 2015年11月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The case with serious complications 2) The case with active double cancer 3) The case with pregnancy, lactation or possibility of pregnancy 4) The case with drug allergy for G-CSF 5) The case with drug allergy for M-VAC or CaG 6) The case without the selection criteria
研究者
相似试验
已完成
不适用
Investigation of anti-tumoral effect and safety of combination therapy LD-GP (low dose gemcitabine and paclitaxel) therapy and sorafenib in patients with cisplatin-resistant advanced urothelial cancer.Cisplatin-resistant urothelial cancerJPRN-UMIN000010957agasaki University Hospital15
招募中
不适用
The study on the antitumor effect of medication for underlying diseases of the patients with unresectable pancreatic carcinoma who undergo standard chemotherapy.JPRN-UMIN000022938ara Medical University40
招募中
1 期
hR3 MAb in combination with chemo-embolization in hepatocellular carcinoma.Liver NeoplasmsCarcinoma, HepatocellularDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesAdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialHepatocellular carcinomaRPCEC00000022Center of Molecular Immunology (CIM)15
招募中
1 期
hR3 monoclonal antibody combined with chemoembolization in mestatatic liver treatment.Primary malignant colon and breast lesion and metastatic liver lesions.Liver NeoplasmsDigestive System NeoplasmsLiver DiseasesDigestive System DiseasesRPCEC00000023Center of Molecular Immunology (CIM)15
招募中
2 期
Evaluation for effects on anticancer efficacy and patient's QOL from dosage adjustment caused by skin toxicity in Panitumumab treatment for Metastatic Colorectal CancerMetastatic Colorectal CancerJPRN-UMIN000015065Gifu Prefectual Tajimi Hospital20